CSF2 and juvenile myelomonocytic leukemia: In previous studies, 15% of patients with juvenile myelomonocytic leukemia (JMML), a disease that is characterized by GM-CSF hypersensitivity and resistance to chemotherapy, were identified containing somatic mutations in Cbl30, 40, 41.